Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.5930
+0.0180 (3.13%)
At close: Oct 2, 2026, 4:00 PM EDT
0.5979
+0.0049 (0.83%)
After-hours: Oct 2, 2026, 7:58 PM EDT
Outlook Therapeutics Market Cap
Outlook Therapeutics has a market cap or net worth of $144.36 million as of October 2, 2026. Its market cap has increased by 212.50% in one year.
Market Cap
144.36M
Enterprise Value
151.55M
1-Year Change
212.50%
Ranking
Category
Stock Price
$0.59
ChartMarket Cap Chart
Since June 14, 2016, Outlook Therapeutics's market cap has increased from $97.37M to $144.36M, an increase of 48.27%. That is a compound annual growth rate of 3.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 144.36M | 42.51% |
| Dec 31, 2025 | 101.30M | 115.21% |
| Dec 31, 2024 | 47.07M | -54.10% |
| Dec 29, 2023 | 102.54M | -63.01% |
| Dec 30, 2022 | 277.20M | -9.11% |
| Dec 31, 2021 | 304.99M | 84.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Compass Therapeutics | 154.28M |
| Molecular Partners AG | 153.82M |
| Tonix Pharmaceuticals Holding | 152.82M |
| Voyager Therapeutics | 150.96M |
| Codexis | 148.93M |
| Acumen Pharmaceuticals | 147.53M |
| Humacyte | 144.87M |
| Tiziana Life Sciences | 144.82M |